Bioabsorbable Stents Market to Grow at $308.9 Million by 2027: Allied Market Research
May 31, 2021 10:41 ET
|
Allied Market Research
Portland, OR, May 31, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Bioabsorbable Stents Market was pegged at $283.6 million in 2019, and is estimated to...
Drug-Eluting Stents Market Size to Hit $8.77 Billion by 2027: Allied Market Research
April 29, 2021 08:30 ET
|
Allied Market Research
Portland, OR, April 29, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Drug-Eluting Stents Market was pegged at $6.38 billion in 2019, and is estimated to...
Heparin Market in the U.S. to Hit USD 1 Bn by 2026: Global Market Insights, Inc.
December 01, 2020 04:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Dec. 01, 2020 (GLOBE NEWSWIRE) -- According to latest report “U.S. Heparin Market by Product (Low Molecular Weight Heparin, Unfractionated Heparin), Application (Venous...
Outlook on the Global Refractory Angina Industry to 2030 - 11-Year Forecast of Refractory Angina Epidemiology
September 09, 2020 06:53 ET
|
Research and Markets
Dublin, Sept. 09, 2020 (GLOBE NEWSWIRE) -- The "Refractory Angina (RA) - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth...
Cardiac Rehabilitation Market To Reach USD 2.29 Billion By 2026 | Reports and Data
March 02, 2020 14:00 ET
|
Reports and Data
New York, March 02, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the cardiac rehabilitation market was valued at USD 1.37 billion in 2018 and is expected to reach...
Drug Eluting Stent Market To Reach USD 8.74 Billion By 2026 | Reports And Data
September 03, 2019 10:53 ET
|
Reports and Data
New York, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Rise in the public health awareness and increased government funding in medical sector with cardiac treatment centers, supportive regulatory environment...
Amaranth Medical Showcases Breadth of BRS Pipeline at TCT, Unveiling 9-mo Interim Imaging Results from 98 micron MAGNITUDE and Update on 115-micron APTITUDE
October 25, 2017 13:21 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Oct. 25, 2017 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds for the interventional cardiology market, will...
Amaranth Medical Initiates Trial of Sub-100-Micron MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold
November 01, 2016 08:00 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Nov. 01, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced the initiation of a clinical study of the Company’s latest-generation...
Amaranth Medical 9-Months Clinical and Imaging Results of the FORTITUDE Sirolimus-Eluting Bioresorbable Scaffold Presented at TCT
October 31, 2016 12:30 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that a presentation of the 9-month clinical and imaging results from the...
Medstar Union Memorial Hospital Makes Pioneering Strides in Coronary Care
August 08, 2016 17:53 ET
|
MedStar Health
BALTIMORE, MD--(Marketwired - August 08, 2016) - MedStar Union Memorial Hospital became the first and only hospital in Maryland to offer a fully dissolvable cardiac stent to patients fighting coronary...